Lexicon Pharmaceuticals, Inc.
(NASDAQ : LXRX)

( )
LXRX After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
Loading LXRX News...
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
-1.00%163.061.3%$781.81m
GILDGilead Sciences, Inc.
0.24%67.261.0%$568.09m
CELGCelgene Corporation
-0.27%124.091.1%$481.61m
BIIBBiogen Inc.
-2.04%268.531.3%$446.03m
REGNRegeneron Pharmaceuticals, Inc.
3.03%394.142.1%$385.16m
INCYIncyte Corporation
-0.14%139.284.3%$353.74m
VRTXVertex Pharmaceuticals Incorporated
20.45%108.012.0%$218.70m
KITEKite Pharma, Inc.
-0.13%78.5117.5%$216.08m
ALXNAlexion Pharmaceuticals, Inc.
1.85%120.721.6%$208.60m
TSROTESARO, Inc.
-1.95%151.8815.6%$193.33m
ILMNIllumina, Inc.
1.08%172.663.4%$164.78m
ESPREsperion Therapeutics, Inc.
-2.44%34.7917.7%$146.82m
CLVSClovis Oncology, Inc.
-3.98%64.3917.2%$135.52m
AUPHAurinia Pharmaceuticals Inc.
1.96%7.308.0%$134.79m
EXELExelixis, Inc.
-0.71%21.135.7%$98.01m

Company Profile

Lexicon Pharmaceuticals, Inc. operates as a biopharmaceutical company which focuses on the development of breakthrough treatments for human disease. It has multiple programs in clinical development for diabetes, irritable bowel syndrome, carcinoid syndrome and other indications. The company was founded by Brian P. Zambrowicz and Arthur T. Sands on July 7, 1995 and is headquartered in The Woodlands, TX.